Abstract
Brain capillary endothelial cells (BCEC), the principal components of the blood—brain barrier (BBB) are interconnected by tight junctions, possess polar membranes and a paucity of pinocytotic vesicles in contrast to capillaries in peripheral organs.1 BCEC’s unique features embrace specialized transport and carrier systems as well as enzymes associated with various metabolic pathways that are essential to sustain the dynamic homeostasis of the brain. Many of these processes are thought to be neuronally regulated. There are a number of excellent reviews regarding the specific function of the BBB and regulation of the cerebral circulation by endothelium.2–4 It is now widely accepted that BCEC not only constitute a permeability barrier to ions and organic molecules (e.g., water, electrolytes, proteins, neurotransmitters), but are also an important secretory organ. BCEC produce agents and factors that may be involved in autocrine and paracrine regulation of the microvascular function of the brain. In general, the substances [e.g., prostacyclin, nitric oxide (NO), and adenosine] produced by these cells are considered to be cytoprotective. However, several other agents which are formed in BCEC and when released in excess may impair perfusion, alter BBB permeability and/or mediate cellular injury (i.e., endothelin I, angiotensin II, thromboxane, leukotrienes, platelet—activating factor, and Superoxide radicals). The secretory function of BCEC can also be modulated by substances released from adjacent cellular elements (other vascular cells, blood and/or brain). There is ample evidence that many of these events play a role in regulating vascular tone, permeability, hemostasis and blood pressure under normal conditions. However, in some pathologic conditions an “oversupply” of some of these agents may adversely affect the BBB permeability and/or surface expression of adhesion molecules (i.e., ICAM—1, VCAM—1, P—selectin) which facilitate binding and ultimately extravasation of circulating leukocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S.I. Rapport. “Blood — Brain Barrier in Physiology and Medicine,” Raven Press, New York (1976).
A.L. Betz, and G.W. Goldstein. Specialized properties and solute transport in brain capillaries. Ann. Rev. Physiol. 48:241 (1986).
F. Joo. The blood—brain barrier in vitro: the second decade. Neurochem. Int. 23:499 (1993).
F.M. Faraci. Regulation of the cerebral circulation by endothelium. Pharmac. Ther. 56:1 (1992).
F. Bacic, S. Uematsu, R.M. McCarron, and M. Spatz. Secretion of immunoreactive endothelin—1 by capillary and microvascular endothelium of human brain. Neurochem. Res. 17:699 (1992).
M. Spatz, D.B. Stanimirovic, S. Uematsu, and R.M. McCarron. Vasoconstrictive peptides induce endothelin—1 and prostanoids in human cerebromicrovascular endothelium. Arn. J. Physiol. 266:C654 (1994).
D.B. Stanimirovic, T. Yamamoto, S. Uematsu, and M. Spatz. Endothelin—1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J. Neurochem. 62:592 (1993).
D.B. Stanimirovic, R.M. McCarron, and M. Spatz. Dexamethasone downregulated endothelin receptors in human cerebromicrovascular endothelial cells. Neuropeptides 26:145 (1994).
N. Kawai, T. Yamamoto, H. Yamamoto, R.M. McCarron, and M. Spatz. Endothelin stimulates ATPase activity in brain capillary endothelium. J. Physiol. (Lond). 480:17P (1994).
D.B. Stanimirovic, R.M. McCarron, N. Bertrand, and M. Spatz. Endothelins release 51Cr from culture human cerebromicrovascular endothelium. Biochem. Biophys. Res. Commun. 26:1 (1993).
R.M. McCarron, L. Wang, D.B. Stanimirovic, and M. Spatz. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci. Lett. 156:31 (1993).
R.M. McCarron, L. Wang, D.B. Stanimirovic, and M. Spatz. Differential regulation of adhesion molecule expression by human cerebrovascular and umbilical vein endothelial cells. Endothelium (1994) (in press).
M. Yanagisawa, H. Kurihara, S. Kimura, et al. Endothelin: a novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411 (1988).
A. Inoue, M. Yanagisawa, S. Kimura, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86:2853 (1989).
G.M. Rubany, and L.H. P. Botelho. Endothelins. FASEB J. 5:2713 (1991).
W.M. MacCumber, A.C. Ross, and H.S. Snyder. Endothelin in the brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. USA 87:2359 (1990).
H. Ehrenreich, H.J. Kehrl, W.R. Anderson, et al. A vasoactive peptide, endothelin—3, is produced by and specifically binds to primary astrocytes. Brain Res. 538:54 (1991).
A. Giaid, J.S. Gibson, T.M. Herrero, et al. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 95:303 (1991).
W.C. Sessa, S. Kaw, M. Hecker, and J.R. Vane. The biosynthesis of endothelin—1 by human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 147:613 (1991).
P.O. Couraud, O. Durieu-Trautmann, D.L. Nguyen, P. Marin, F. Gilbert, and A.D. Strosberg. Functional endothelin—1 receptors in rat astrocytoma C6. Eur. J. Pharmacol. 206:191 (1991).
P.A. Revest, N.J. Abbott, and J.I. Gillespie. Receptor — mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res. 549:159 (1991).
P. Vigne, A. Ladoux, and C. Frelin. Endothelins activate Na+/H+ exchange in brain capillary endothelial cells via a high—affinity endothelin—3 receptor that is not coupled to phospholipase C. J. Biol. Chem. 266:5925 (1991).
J. Chopra, J.H. Joist, R.O. Webster. Loss of 51chromium, lactate dehydrogenase, and 111indium as indicators of endothelial cell injury. Lab. Invest. 57:578 (1987).
A. Villacara, M. Spatz, R.F. Dodson, C. Corn, and J. Bembry. Effect of arachidonic acid on cultured cerebromicrovascular endothelium: Permeability, lipid peroxidation and membrane “fluidity”. Acta Neuropathol. 78:310(1989).
R.M. McCarron, S. Uematsu, S. Merkel, D. Long, J. Bembry, and M. Spatz. The role of arachidonic acid and oxygen radicals on cerebromicrovasculature endothelial permeability. Acta Neurochem. Suppl. 51:61 (1990).
P. Vigne, L. Lund, and C. Frelin. Cross—talk among cyclic AMP, cyclic GMP, and Ca2+—dependent intracellular signalling mechanisms in brain capillary endothelial cells. J. Neurochem. 62:2269 (1994).
A. Ermisch. Peptide receptors of the blood—brain barrier and substrate transport into the brain. Prog. Brain Res. 91:155 (1992).
J. Widimsky Jr., K. Horky, and J. Dvorakova. Plasma endothelin—1, — 2 levels in mild and severe hypertension. J. Hypertens. 9 (Suppl. 6):S194 (1991).
R. Suzuki, H. Masaoka, Y. Hirata, et al. The role of endothelin — 1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 77:96 (1992).
A.A. Khraibi, D.M. Heublein, and F.G. Knox. Increased plasma level of endothelin — 1 in the Okamoto spontaneously hypertensive rat. Mayo Clin. Proc. 68:42 (1993).
F.C. Barone, M.Y.-T. Globus, W.J. Price, et al. Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow and Metab. 14:337 (1994).
J. Vane, E.E. Anggard, and R.M. Botting. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323:27 (1990).
I.M. Macrae, M.I. Robinson, D.I. Graham, J.L. Reid, and J. McCulloch. Endothelin—1 reduction in cerebral blood flow: dose—dependency, time course and neuropathological consequences. J. Cereb. Blood Flow and Metab. 13:276(1993).
G.Z. Feuerstein, J.L. Gu, E.H. Olshtein, E.C. Barone, and I.L. Yue. Selective endothelin receptor (ETA) antagonist is neuroprotective in gerbil transient forebrain ischemia. Stroke 25:264 (1994).
J.G. Filep, M.G. Sirois, E. Foldes-Filip, et al. Enhancement by endothelin — 1 of microvascular permeability via the activation of ETA receptors. Br. J. Pharmacol. 109:880 (1993).
A. Halim, N. Kanayama, E.E. Maradny, K. Maehara, and T. Terao. Coagulation in vivo microcirculation and in vitro caused by endothelin — 1. Thromb. Res. 72:203 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Spatz, M., Stanimirovic, D., McCarron, R.M. (1995). Endothelin as a Mediator of Blood-Brain Barrier Function. In: Greenwood, J., Begley, D.J., Segal, M.B. (eds) New Concepts of a Blood—Brain Barrier. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1054-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1054-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1056-1
Online ISBN: 978-1-4899-1054-7
eBook Packages: Springer Book Archive